Yue Su

The regulatory role of PDE4B in the progression of inflammatory function study

Yuanyuan Xu, Jiaxiang Ding, Huan Zhou, 2022, Frontiers in Pharmacology.

Research progress on microRNA in gout

Yuanyuan Xu, Hongju Wang, Jiaxiang Ding, 2022, Frontiers in Pharmacology.

Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone® in healthy Chinese male volunteers

Minhui Zhu, Bingyan Liu, Xiaoyi Li, 2021, Expert opinion on drug metabolism & toxicology.

Knowledge mapping of global trends for myasthenia gravis development: A bibliometrics analysis

Fan Jiang, Ting Chang, Yue Su, 2023, Frontiers in Immunology.

Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis

Z. Ruan, Zhuyi Li, Ting Chang, 2023, Frontiers in Immunology.

Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study

S. Luo, X. Huan, Z. Ruan, 2023, Frontiers in Immunology.

Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [^14C] SHC014748M in healthy Chinese subjects following oral administration

Minhui Zhu, Bingyan Liu, Xiaoli Li, 2022, Cancer Chemotherapy and Pharmacology.

Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study

Minhui Zhu, Bingyan Liu, Ying Wang, 2023, BMC Pharmacology and Toxicology.

FTO represses NLRP3‐mediated pyroptosis and alleviates myocardial ischemia–reperfusion injury via inhibiting CBL‐mediated ubiquitination and degradation of β‐catenin

H. Che, Shenglin Ge, Zhixiang Guo, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects

Xiao Chen, Zhijun Li, Minhui Zhu, 2022, Clinical pharmacology in drug development.

The role of CSTF2 in cancer: from technology to clinical application

Yue Su, Yuanyuan Xu, Jiaxiang Ding, 2023, Cell cycle.